The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of Beijing Tong Ren Tang Healthcare Investment Co., Ltd. 北京同仁堂醫養投資股份有限公司 (A joint stock company incorporated in the Pe ...

Core Viewpoint - Charming Medical Limited has successfully completed its initial public offering (IPO) on the Nasdaq Capital Market, raising a total of $6.4 million from the sale of 1,600,000 Class A ordinary shares at a price of $4.00 per share [1][2]. Group 1: Offering Details - The IPO consisted of 1,600,000 Class A ordinary shares priced at $4.00 each, with trading commencing on October 21, 2025 [1]. - The total gross proceeds from the offering amount to $6.4 million, which will be utilized for business expansion, strategic investments, research and development, and general corporate purposes [2]. - An over-allotment option has been granted to underwriters for an additional 240,000 shares, which could increase gross proceeds to approximately $7.36 million if fully exercised [3]. Group 2: Company Background - Charming Medical Limited is a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies and products, integrating TCM principles with modern technology [7]. - The company operates four wellness centers in Hong Kong, offering services aimed at addressing women's health issues, including womb-warming therapy and prenatal massage [7]. - Under the "Beauty Lab" brand, the company develops TCM-inspired supplements and beauty products, focusing on improving women's health and vitality [7].

As filed with the U.S. Securities and Exchange Commission on July 30, 2025. Registration No. 333-287258 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 _____________________________________ Charming Medical Limited (Exact name of registrant as specified in its charter) _____________________________________ | British Virgin Islands | 2833 | Not Applicable | | --- | --- | --- | | (State or other jurisdicti ...

The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of Beijing Tong Ren Tang Healthcare Investment Co., Ltd. 北京同仁堂醫養投資股份有限公司 (A joint stock company incorporated in the Pe ...

As filed with the U.S. Securities and Exchange Commission on May 27, 2025. Registration No. 333-287258 AMENDMENT NO. 1 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________ Charming Medical Limited (Exact name of registrant as specified in its charter) _____________________________________ | British Virgin Islands | 2833 | Not Applicable | | --- | --- | --- | | (State or other jurisdictio ...

As filed with the U.S. Securities and Exchange Commission on September 4, 2024 Registration No. 333-260183 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 PRE-EFFECTIVE AMENDMENT NO. 20 TO Form S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 JUPITER NEUROSCIENCES, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 2834 47-4828381 (Primary Standard Industrial Classification Code Number) Jupite ...